The erbB‐3 Gene in human pancreatic cancer

Nicholas R. Lemoine, Maria Lobresco, Hing Leung, Claire Barton, Christine M. Hughes, Sally A. Prigent, William J. Gullick, Günter Klöppel

Research output: Contribution to journalArticlepeer-review

95 Scopus citations

Abstract

Abnormalities of the type 1 growth factor receptor family have been implicated in the pathogenesis of pancreatic cancer. There is evidence for a potential autocrine loop involving overexpression of the epidermal growth factor (EGF) receptor and its ligands, as well as overexpression of the erbB‐2 receptor. A third member of this receptor family, erbB‐3, has recently been recognized and found to be abnormally expressed in some types of human cancer. In this study we show that overexpression of the erbB‐3 protein occurs very frequently in carcinoma of the exocrine pancreas and also in chronic pancreatitis. We found no evidence of amplification or rearrangement of the erbB‐3 gene by Southern blot analysis of DNA from pancreatic cancer cells lines.

Original languageEnglish
Pages (from-to)269-273
Number of pages5
JournalJournal of Pathology
Volume168
Issue number3
DOIs
StatePublished - Nov 1992
Externally publishedYes

Keywords

  • Type 1 growth factor receptor
  • cancer
  • erbB‐3
  • immunohistochemistry
  • pancreas

Fingerprint

Dive into the research topics of 'The erbB‐3 Gene in human pancreatic cancer'. Together they form a unique fingerprint.

Cite this